Ribavirin Injection is a broad-spectrum antiviral drug that has inhibitory effects on a variety of viruses, including respiratory syncytial virus, influenza virus, hepatitis A virus, and adenovirus. It is primarily used to treat viral pneumonia and bronchitis caused by respiratory syncytial virus.
This document is the package insert for Xinhua Pharmaceutical Ribavirin Injection, an antiviral injection with a specification of 1 ml: 0.1 g. It states the composition, indications, dosage, adverse reactions, contraindications, precautions, and other product information.
The insert also covers use in adults and children, drug interactions, overdose, pharmacology, pharmacokinetics, storage, packaging, validity period, approval number, and manufacturer details. This manual is written in Chinese.
| Specification | 1 ml: 0.1 g |
|---|---|
| Molecular formula | C8H12N4O5 |
| Molecular weight | 244.21 |
| Shelf life | 30 months |
| Packaging | 1 ml ampoule, 10 ampoules per box |
| Storage | Sealed storage |
It is an antiviral drug used for viral pneumonia and bronchitis caused by respiratory syncytial virus.
It is diluted with sodium chloride injection or 5% glucose injection to a solution containing 1 mg per ml, then given by slow intravenous drip.
Adults receive 0.5 g twice daily; children receive 10-15 mg/kg per day in two doses; each drip lasts at least 20 minutes and the course is 3-7 days.
Common adverse reactions include anemia and fatigue, which disappear after stopping the drug.
It is contraindicated in people allergic to it and in pregnant women.